3D heart mapping may unlock secrets of persistent AF treatment
NCT ID NCT04229160
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study uses a noninvasive 3D mapping system to look at the heart's electrical activity in 50 people with persistent atrial fibrillation (AF) lasting over 6 months. Researchers want to see how the heart changes after a standard ablation procedure and what factors might predict success. The goal is to better understand why AF comes back and improve future treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors better predict who will benefit from atrial fibrillation ablation and guide more personalized treatment strategies.
What could go wrong
This is an observational study with only 50 participants, so results may not apply to everyone. It is not testing a new treatment, so direct patient benefits are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION, PERSISTENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Caen University Hospital
Caen, France
-
Dieppe Hospital
Dieppe, France
-
Groupe Hospitalier du Havre
Le Havre, France
-
Rouen University Hospital
Rouen, France